These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24004686)

  • 1. Understanding recurrent herpes labialis management and impact on patients' quality of life: the HERPESCOPE study.
    Dreno B; Malkin JE; Saiag P
    Eur J Dermatol; 2013; 23(4):491-9. PubMed ID: 24004686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management and recommendations for access to antiviral therapy of herpes labialis.
    Cunningham A; Griffiths P; Leone P; Mindel A; Patel R; Stanberry L; Whitley R
    J Clin Virol; 2012 Jan; 53(1):6-11. PubMed ID: 21889905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France.
    Dréno B; Malkin JE; Saiag P; Batuji-Garin S
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1458-60. PubMed ID: 22098071
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical n-docosanol for management of recurrent herpes labialis.
    Treister NS; Woo SB
    Expert Opin Pharmacother; 2010 Apr; 11(5):853-60. PubMed ID: 20210688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public awareness and knowledge of herpes labialis.
    Pica F; Volpi A
    J Med Virol; 2012 Jan; 84(1):132-7. PubMed ID: 22028143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
    Busch R; Graubaum HJ; Gruenwald J; Faergemann J
    Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey on the prevalence of orofacial herpes in France: the INSTANT Study.
    Lorette G; Crochard A; Mimaud V; Wolkenstein P; Stalder JF; El Hasnaoui A
    J Am Acad Dermatol; 2006 Aug; 55(2):225-32. PubMed ID: 16844503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
    Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
    J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical management measures for patients with recurrent herpes labialis.
    St Pierre SA; Bartlett BL; Schlosser BJ
    Skin Therapy Lett; 2009; 14(8):1-3. PubMed ID: 20054504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent herpes labialis: a pilot study of the efficacy of zinc therapy.
    Femiano F; Gombos F; Scully C
    J Oral Pathol Med; 2005 Aug; 34(7):423-5. PubMed ID: 16011612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of herpes simplex labialis.
    Spruance SL; Kriesel JD
    Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
    Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
    J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes labialis and genitalis in general medicine].
    Gallais J; Boisnault P; Morel F; Clerc P; Letrillard L; Hebbrecht G
    Ann Dermatol Venereol; 2000; 127(6-7):596-602. PubMed ID: 10930857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis.
    Formica M; Kabbara K; Clark R; McAlindon T
    J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and prevention of recurrent herpes labialis in immunocompetent patients.
    Gilbert SC
    Herpes; 2007 Dec; 14(3):56-61. PubMed ID: 18371287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol as a potential therapeutic agent for recurrent herpes labialis.
    El-Farrash MA; Youssef JM; El-Mongy SE
    J Med Dent Sci; 2003 Jun; 50(2):147-54. PubMed ID: 12968636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.